Page last updated: 2024-08-24

nelfinavir and Genetic Predisposition

nelfinavir has been researched along with Genetic Predisposition in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aweeka, F; Burchett, SK; Capparelli, E; Fenton, T; Kovacs, A; Nachman, S; Saitoh, A; Sarles, E; Singh, KK; Spector, SA; Wiznia, A	1

Other Studies

1 other study(ies) available for nelfinavir and Genetic Predisposition

Article	Year
CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 54, Issue:3 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2C19; Gene Expression Regulation; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; HIV Infections; HIV-1; Humans; Nelfinavir; Retrospective Studies; RNA, Viral; Treatment Outcome	2010

Article

Year

CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy.

Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 54, Issue:3

Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2C19; Gene Expression Regulation; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; HIV Infections; HIV-1; Humans; Nelfinavir; Retrospective Studies; RNA, Viral; Treatment Outcome

2010